Dr. Anna Jane Fongwitoo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1625 Lawton Trl, Germantown, TN 38138 Phone: 901-347-3243 |
Dr. Justin Daniel Griner, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7650 W Farmington Blvd, Germantown, TN 38138 Phone: 901-754-8400 |
Yasmeen Elaskary Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7650 W Farmington Blvd, Germantown, TN 38138 Phone: 901-754-8400 |
Steven J. Thornton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9235 Poplar Ave, Germantown, TN 38138 Phone: 901-214-0800 Fax: 901-214-0800 |
Carrie Keobounruang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9325 Poplar Ave, Germantown, TN 38138 Phone: 901-309-1609 |
Kirandeep Kaur, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9325 Poplar Ave, Germantown, TN 38138 Phone: 901-309-1609 |
Mrs. Sara W Reese, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9235 Poplar Ave, Germantown, TN 38138 Phone: 901-214-0800 |
Robert B Walter, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8584 Redbud Trail Cv, Germantown, TN 38139 Phone: 901-737-7885 |
Christian Dodd, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9235 Poplar Ave, Germantown, TN 38138 Phone: 901-214-0800 |
Dr. Mitzi J Stover, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7650 W Farmington Blvd, Germantown, TN 38138 Phone: 901-754-8400 |
Mrs. Linda Lee Buller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9235 Poplar Ave, Germantown, TN 38138 Phone: 901-214-0800 Fax: 901-214-0800 |
News Archive
Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.
A group of Canadian researchers has recently conducted a comprehensive study investigating the long-term effects of COVID-19.
AlphaRx Inc. announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO), to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation of an intracellular neuroprotectant that employs AlphaRx's proprietary nano-emulsion formulation technology.
Testing for a new group of genes associated with testicular cancer has improved the ability to identify men at greatest risk of the disease, say researchers. Scientists at The Institute of Cancer Research, London, found that by testing for 19 new genetic factors in addition to the 25 risk genes already known, they could identify the 1% of men at highest risk.
› Verified 4 days ago